Rising Surgical Procedures Drive Growth In Flowable Hemostats Market Driver: A Major Catalyst in the Evolution of the Flowable Hemostats Market in 2025

How Are the key drivers contributing to the expansion of the flowable hemostats market?
The upward trend in surgical procedures is anticipated to boost the growth of the flowable hemostats market. This surge is being influenced by an older population and technological advancements, both leading to an increased need for age-related surgeries and rendering surgeries safer and more widely available. Flowable hemostats champions in surgical procedures as it aids in stopping bleeding in hard-to-reach places or areas where conventional methods aren't efficient. A report released in June 2024 by the International Society of Aesthetic Plastic Surgery (ISAPS), a non-governmental professional organization based in the US, revealed that there was a 3.4% upsurge in 2023 in the total count of surgical and non-surgical procedures, amounting to 34.9 million, as opposed to the preceding year. Consequently, the rise in surgical procedures is steering the growth of the flowable hemostats market.

Get Your Flowable Hemostats Market Report Here:
https://www.thebusinessresearchcompany.com/report/flowable-hemostats-global-market-report

What growth opportunities are expected to drive the flowable hemostats market's CAGR through 2034?
In the past few years, there has been a substantial increase in the flowable hemostats market size. The market is projected to rise from $0.95 billion in 2024 to $1.02 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. The growth witnessed during the historical period is due to the surge in elective surgeries, wider acceptance of personalized medicine, a boost in healthcare expenditure, and the enlargement of healthcare facilities in emerging markets.

In the coming years, a solid growth trajectory is anticipated for the flowable hemostats market, with it set to reach $1.37 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.6%. This growth during the forecast period can be credited to multiple factors such as the surge in surgical procedures, increasing chronic disease prevalence, a growing demand for minimally invasive surgeries, and an ageing population in need of surgical care. The forecast period will also witness significant trends including the incorporation of superior bioengineered materials, the emergence of smart hemostatic products, the use of robotic-assisted and minimally invasive surgical procedures, the adoption of patient-tailored and personalized hemostatic solutions, and advanced customization of hemostats.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20552&type=smp

What are the emerging trends shaping the future of the flowable hemostats market?
Major firms in the flowable hemostats market are turning their attention to the creation of more technologically advanced hemostatic agents such as no-swell technology, to keep pace with the dynamic requirements of surgical operations. The term no-swell technology points to a hemostatic agent characteristic that inhibits fluid absorption and expansion, which makes it especially suited for procedures where swelling might trigger complications. As an example, Medcura Inc., a surgical technology company based in the United States, in January 2023, earned a breakthrough device designation from the FDA for its LifeGel flowable technology that restricts bleeding during surgeries where swelling is not desirable. Medcura's LifeGel stands as the premier and sole flowable hemostatic gel made to counter distinctive swelling issues related to hemostats. This absorbent agent doesn't swell since it's completely hydrated and ready-to-use, possibly lessening the risk factors linked to swelling like nerve damage and paralysis. Besides being cost-friendly, it holds its antimicrobial traits, has relative transparency, and sticks to tissues, providing a safe and highly efficient method for restricting bleeding in intricate surgical procedures.

Which growth-oriented segments of the flowable hemostats market are leading the industry's development?
The flowable hemostats market covered in this report is segmented -

1) By Product: Active Hemostats, Passive Hemostats, Combination Hemostats
2) By Material: Porcine Gelatin, Bovine Gelatin
3) By Application: General Surgery, Cardiac Surgery, Vascular Surgery, Neuro And Spine Surgery, Orthopedic Surgery, Other Applications
4) By End User: Hospital And Clinics, Ambulatory Surgery Centers

Subsegments:
1) By Active Hemostats: Fibrin Sealants, Thrombin-Based Hemostats, Collagen-Based Hemostats, Biodegradable Polymer Hemostats
2) By Passive Hemostats: Gauze-Based Hemostats, Sponges and Pads, Cellulose-Based Hemostats, Granule-Based Hemostats
3) By Combination Hemostats: Fibrinogen and Thrombin Combination Products, Collagen and Fibrin Combination Products, Synthetic Combination Hemostats, Bioresorbable Combination Hemostats

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20552

What regions are leading the charge in the flowable hemostats market?
North America was the largest region in the flowable hemostats market in 2024. The regions covered in the flowable hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the flowable hemostats market?
Major companies operating in the flowable hemostats market are Pfizer Inc., Johnson & Johnson Services Inc., Medtronic plc, Medline Industries Inc., Stryker Corporation, Baxter International Inc., B Braun Melsungen AG, Becton Dickinson and Company, Cook Medical Inc., Teleflex Incorporated, Mallinckrodt Pharmaceuticals, Integra LifeSciences Holdings Corporation, Gelita Medical GmbH, Ferrosan Medical Devices A/S, Marine Polymer Technologies Inc, Axio Biosolutions Private Limited, Hemostasis LLC, Aegis Lifesciences Private Limited, Medcura Health Inc, Arch Therapeutics Inc., Starch Medical Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20552&type=smp

What Is Covered In The Flowable Hemostats Global Market Report?

•Market Size Forecast: Examine the flowable hemostats market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the flowable hemostats market for a structured understanding.
•Key Players Overview: Analyze major players in the flowable hemostats market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the flowable hemostats market.
•Segment Contributions: Evaluate how different segments drive overall growth in the flowable hemostats market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the flowable hemostats market.
•Industry Challenges: Identify potential risks and obstacles affecting the flowable hemostats market.
•Competitive Landscape: Review strategic developments in the flowable hemostats market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.